Lisl J. Dunlop
Partner
Email Page
Profile
Experience
Honors
News
Insights
Education
Admissions
LinkedIn
{ Bio Portrait }

Lisl Dunlop has more than twenty-five years of experience in antitrust and competition issues, including counseling, litigation, and transactions. Lisl guides clients through the antitrust-related aspects of mergers and acquisitions, joint ventures and other combinations, and sales and distribution matters. She also represents clients in antitrust agency investigations, and has represented major corporations in complex antitrust litigations.

Lisl has significant experience advising leading U.S. and multinational companies in a broad range of industries, including the media, technology, and healthcare sectors. For her healthcare clients, Lisl provides antitrust and strategic advice in evaluating value-based payment initiatives, the establishment and operation of ACOs and independent physician networks, financial and clinical integration issues, and other transactions and collaborations.

Lisl began her career in Australia, and in addition to the U.S. has also practiced in the UK. Her wide-ranging international experience includes appearing before U.S. federal and state antitrust enforcement agencies, the European Commission, and UK and Australian antitrust authorities. Additionally, she has coordinated the multijurisdictional defense of transactions throughout the world. Lisl’s experience in competition matters in a broad range of jurisdictions brings added value to clients that conduct business internationally and interact with different legal systems and regulators.

Regularly recognized as an antitrust leader, Lisl has been ranked in Chambers USA, Legal 500, Who’s Who Legal, and Global Competition Review and is a frequent author and speaker on issues involving antitrust and competition law.

More » « Less

Professional Activities

  • New York State Bar Association Antitrust Section – Chair (2016); Executive Committee member
  • American Bar Association Section of Antitrust – Vice Chair, Mergers & Acquisitions Committee
  • American Health Lawyers Association, Antitrust Practice Group—Member
  • Law360 Competition Editorial Advisory Board (2019)

Experience

  • Represented Textron Inc. in pilot training joint venture with FlightSafety Inc.
  • Represented Peter Adderton and Boost International in opposing the Sprint/T-Mobile merger
  • Authored amicus brief for Nashville Songwriters’ Association International in United States v. Broadcast Music, Inc., Second Circuit, 2017
  • Defended Kaiser Foundation Health Plan and Kaiser Foundation Hospitals in NorthBay Healthcare Group, Inc. v. Kaiser Foundation Health Plan, Inc. in the Northern District of California
  • Represented Mount Sinai in its acquisition of South Nassau Community Hospital
  • Represented Stamps.com in its acquisitions of Endicia and MetaPack
  • Represented Mann+Hummel in its acquisitions of Affinia and Tri-Dim
  • Represented Hetero in the sale of Invagen to Cipla
  • Represented Lutheran Medical Center in its acquisition by NYU/Langone
  • Represented Textron/Cessna in its acquisition of Beechcraft
  • Represented Ardagh Group in its acquisition of Saint Gobain Containers

* Includes matters handled prior to joining Axinn

Honors

  • Chambers USA, Antitrust – New York (2010-2018)
  • Legal 500 (2012-2014)
  • Named a top author in JD Supra's Readers' Choice Awards (2017-2018)
  • Listed in Global Competition Review's International Who's Who of Competition Lawyers
  • Super Lawyers, New York Metro (2011-2018)

Thought Leadership

    Co-author, New York Attorney General's Cartel Bust Is Just the Beginning, Crain’s New York Business, June 18, 2018

    Co-author, Net Neutrality: From Rules to Enforcement, Electronic Retailing Association, December 20, 2017

    Certificates of Public Advantage: Bypassing the FTC in Healthcare Mergers? Competition, Vol 27, No. 1, Winter 2017-2018

    Co-author, When A Firm Is "Failing": CentraCare Vs. Energy Solutions, Law360 Expert Analysis, August 25, 2017

    Why Amazon's Whole Foods Buy Is Likely to Be Cleared, Law360, June 27, 2017

    Co-author, Merger Control in the United States: OverviewPractical Law, Thomson Reuters, June 1, 2017

    Geographic Market Definition in Hospital Merger Antitrust Enforcement, New York Law Journal, January 23, 2017

    Co-author, Restraints of Trade and Dominance in the United States: Overview, Practical Law, Thomson Reuters, June 1, 2016

    Co-author, Merger Control in the United States: OverviewPractical Law, Thomson Reuters, June 1, 2016

    Co-author, Merger Control in the United States: OverviewPractical Law, Thomson Reuters, September 1, 2015

Restraints of Trade and Dominance in the United States: Overview, Practical Law, Thomson Reuters, September 1, 2015

Co-author, FTC's Use of "Disgorgement" Poses New Risks for Healthcare IndustryModern Healthcare, August 24, 2015

Messages in A Bottle: Defense Perspectives from the Ardagh/Saint Gobain Case (with Heather Kafele), The Threshold, Summer 2014

Allocating Antitrust Risk in M&A Agreements (with Dale Collins), CPI Antitrust Chronicle, April 2013

The FTC Is Shifting Gears on Monetary Remedies: Should You Be Worried? The Antitrust Counselor, Vol. 6.4, October 2012

Mergers and Acquisitions, 2008 Annual Review of Antitrust Law Developments, ABA 2009

The Many Faces of Administrative Adjudication in the European Union (with Michael Asimow), 61 Admin. L. Rev. 131 (2009)

Mergers and Acquisitions2007 Annual Review of Antitrust Law Developments, ABA 2008

Administrative Law of the European Union: Adjudication (with Michael Asimow), in Administrative Law of the European Union, Berman, Koch and O’Reilly, eds., ABA 2008

More » « Less

Events

Education

  • LLM – Cornell University Law School (1997)
  • LLB – University of Sydney (1991)
  • BSc – University of Sydney (1991)

Admissions

  • New York
  • District of Columbia
  • Australia
  • England and Wales